MICHAEL PATRICK MILLER - 01 Feb 2026 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role: Director
Signature: /s/ Raymond Furey (Attorney-in-Fact)
Issuer symbol: RIGL
Transactions as of: 01 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Feb 2026, 16:09:48 UTC
Previous filing: 12 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
MILLER MICHAEL PATRICK	Director	RIGEL PHARMACEUTICALS, INC., 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO	/s/ Raymond Furey (Attorney-in-Fact)	03 Feb 2026	0001236514

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RIGL	Stock Option (right to buy)	Award	$0	+12,000		$0.000000	12,000	01 Feb 2026	Common Stock	12,000	$34.86	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shall vest in equal monthly installments over a period beginning on February 1, 2026 and ending on the date of the annual meeting at which the Reporting Person is first scheduled to be considered for election by the stockholders, subject to the Reporting Person's continuous service on the Company's Board of Directors.